Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Ian@SI who wrote (20052)	5/17/2006 1:43:45 PM
From: kenhott	Read Replies (1) \| Respond to of 52153

<MRK estimates of Cerical Cancer - 9,000 in the USA yet almost 300,000 worldwide> The Merck U.S. number for Invasive CC looks a little low but looks like others numbers that I have seen. This is the first time I have seen a number for worldwide. But if you ballpark 300M for U.S. population and 6.5B for world, using 9.7k in U.S., you would get about 200k for worldwide. I have seen numbers of 15k for USA so that would basically bridge the difference. But there must be some delta due to testing differences USA vs. ex-USA because Invasive Cervical Cancer is the "end" if you don't catch it earlier. How about some MEDI? :)